In the grand circus of life, there’s always a new act to keep us entertained. And today, ladies and gentlemen, we turn our attention to our great state of Connecticut, where the green leaves of controversy are rustling in the wind.
Enter Theraplant, the first cannabis producer in the state. Ah, Theraplant, the pioneer, the trailblazer, the one who dared to tread where no one had before. The first to bring mulched up gerbil food to the table. They opened their doors in 2014, and since then, it’s been a rollercoaster ride of highs and lows, pun absolutely intended.
But alas, the winds of change are blowing, and they’re carrying the scent of investigation. The state Department of Consumer Protection (DCP) has decided to take a closer look at our dear friends over at Theraplant. The nature of the investigations? Well, that’s a secret as tightly rolled as a premium joint.
Now, don’t get me wrong. Theraplant insists they only sell flower that meets all regulatory and testing requirements. But the DCP, they’ve got their magnifying glasses out and their detective hats on. They’ve initiated two label-based recalls. Label-based, mind you. Nothing to do with the quality of the product.
And let’s not forget the game of musical chairs that’s been going on with the ownership of Theraplant. Sold twice since its inception, it’s now in the hands of DXR Finance 31. A foreclosure agreement wiped a cool $4million of debt off the books. Not a bad deal, if you ask me. Gotta’ love big business…
So, as the smoke clears, we wait with bated breath to see what the future holds for Theraplant. Will they emerge from this cloud unscathed, or will this investigation harshly brow beat them? Only time will tell, my friends. Only time will tell.
Keep it weird,
